🕵️ Anteris Technologies Global Corp. ($AVR)
SEC insider & ownership activity, last 12 months · CIK 2011514 · every row links its SEC filing
Over the last 12 months insiders sold $4.2M against $35.4M of open-market buying. L1 Capital PTY Ltd bought $35.3M in discretionary trades (Oct–Jul). L1 Capital PTY Ltd trimmed 19.9% → 13.6%; SIO Capital Management, LLC added 4.9% → 5.5%. No red-flag 8-Ks in the window.
Monthly net open-market insider flow, last 12 months (up = net buying)
Insider flow
2 buyers, $35.4M (3 lots) · 1 seller, $4.2M (4 lots)
| Insider | Buys | Bought | Sells | Sold | Last |
|---|---|---|---|---|---|
| L1 Capital PTY Ltd | 2 | $35.3M | 4 | $4.2M | Jul 28, 2026 |
| Knight Susan Elizabeth | 1 | $102K | 0 | – | Jun 2, 2026 |
5%+ holders
| Holder | Stake | Class | Schedule | Event | |
|---|---|---|---|---|---|
| Medtronic PLC | 16.2% | 13D | Jan 22, 2026 | filing ↗ | |
| Covidien Group S.A.R.L. | 16.2% | 13D | Jan 22, 2026 | filing ↗ | |
| L1 Capital PTY Ltd | 13.6% | 13G | Feb 5, 2026 | filing ↗ | |
| Nantahala Capital Management, LLC | 6.3% | 13G | May 15, 2026 | filing ↗ | |
| Wilmot B. Harkey | 6.3% | 13G | May 15, 2026 | filing ↗ | |
| Daniel Mack | 6.3% | 13G | May 15, 2026 | filing ↗ | |
| SIO Capital Management, LLC | 5.5% | 13G | May 4, 2026 | filing ↗ | |
| Blackrock, Inc. | 5.0% | 13G | Apr 27, 2026 | filing ↗ |
Planned insider sales (Form 144)
No sale notices filed in the last 12 months.
Material events (8-K)
| Item | Event date | |
|---|---|---|
| Material agreement (1.01) | May 22, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | May 22, 2026 | filing ↗ |
| Officer/director changes (5.02) | May 12, 2026 | filing ↗ |
| Earnings (2.02) | May 12, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | May 12, 2026 | filing ↗ |
| Agreement terminated (1.02) | Apr 29, 2026 | filing ↗ |
| Material agreement (1.01) | Apr 23, 2026 | filing ↗ |
| Officer/director changes (5.02) | Feb 26, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Feb 26, 2026 | filing ↗ |
| Earnings (2.02) | Feb 26, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Feb 26, 2026 | filing ↗ |
| Reg FD disclosure (7.01) | Jan 22, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Jan 22, 2026 | filing ↗ |
| Material agreement (1.01) | Jan 20, 2026 | filing ↗ |
| Unregistered equity sale (3.02) | Jan 20, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Jan 20, 2026 | filing ↗ |
| Officer/director changes (5.02) | Dec 15, 2025 | filing ↗ |
| Shareholder vote (5.07) | Dec 3, 2025 | filing ↗ |
| Agreement terminated (1.02) | Nov 26, 2025 | filing ↗ |
| Reg FD disclosure (7.01) | Nov 17, 2025 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Nov 17, 2025 | filing ↗ |
| Earnings (2.02) | Nov 12, 2025 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Nov 12, 2025 | filing ↗ |
| Reg FD disclosure (7.01) | Nov 3, 2025 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Nov 3, 2025 | filing ↗ |
| Reg FD disclosure (7.01) | Oct 27, 2025 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Oct 27, 2025 | filing ↗ |
| Unregistered equity sale (3.02) | Oct 27, 2025 | filing ↗ |
| Other events (8.01) | Oct 27, 2025 | filing ↗ |
| Unregistered equity sale (3.02) | Oct 23, 2025 | filing ↗ |